Home/Filings/4/0001209191-16-156578
4//SEC Filing

Oncobiologics, Inc. 4

Accession 0001209191-16-156578

$OTLKCIK 0001649989operating

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 6:00 PM ET

Size

5.2 KB

Accession

0001209191-16-156578

Insider Transaction Report

Form 4
Period: 2016-12-21
Bahrt Kenneth
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2016-12-21+50,00080,985 total
Footnotes (2)
  • [F1]This security represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]The shares underlying this restricted stock unit award vests in two equal installments on each of December 21, 2017 and December 21, 2018, in each case subject to the Reporting Person's continuous service to the Issuer through each such date. In addition, 100% of the shares underlying the restricted stock unit award will satisfy the time-based vesting restrictions upon the occurrence of a change of control, subject to continued service through such event.

Issuer

Oncobiologics, Inc.

CIK 0001649989

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001649989

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:00 PM ET
Size
5.2 KB